Showing results (81-90 of 138) with videos related to
Sort By:
Pageof 14
Cancer Immunology, Immunotherapy : CII|January 23, 2023
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancersJordi Pfeifer Serrahima, Congcong Zhang, Pranav Oberoi, et al.JAMA|April 18, 2013
Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trialBirgit Assmus, Dirk H Walter, Florian H Seeger, et al.Journal of the National Cancer Institute|December 8, 2015
ErbB2/HER2-Specific NK Cells for Targeted Therapy of GlioblastomaCongcong Zhang, Michael C Burger, Lukas Jennewein, et al.Cytotherapy|August 11, 2014
Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus diseaseMarcus Odendahl, G Ulrich Grigoleit, Halvard Bönig, et al.European Journal of Heart Failure|October 1, 2009
Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trialVolker Schächinger, Birgit Assmus, Sandra Erbs, et al.NPJ Precision Oncology|October 14, 2023
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancerDavid Digomann, Max Heiduk, Charlotte Reiche, et al.The New England Journal of Medicine|September 23, 2006
Transcoronary transplantation of progenitor cells after myocardial infarctionBirgit Assmus, Jörg Honold, Volker Schächinger, et al.Frontiers in Immunology|June 23, 2025
Dysregulated monocyte compartment in PACS patientsRomy Kronstein-Wiedemann, Madeleine Teichert, Elisa Michel, et al.European Heart Journal|December 17, 2011
Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrowBirgit Assmus, Masayoshi Iwasaki, Volker Schächinger, et al.Journal of Clinical Medicine|May 19, 2019
Expression of Glypican 3 is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum ExosomesMohammad Rahbari, Mathieu Pecqueux, Daniela Aust, et al.Pageof 14